Literature DB >> 21846724

Lysosomal storage causes cellular dysfunction in mucolipidosis II skin fibroblasts.

Takanobu Otomo1, Katsumi Higaki, Eiji Nanba, Keiichi Ozono, Norio Sakai.   

Abstract

Mucolipidosis II (ML-II) is a fatal inherited metabolic disease caused by deficiency of GlcNAc-phosphotransferase, which plays a role in generating the mannose 6-phosphate recognition marker on lysosomal enzymes. In ML-II, many lysosomal acid hydrolases are mistargeted out of cells, and lysosomes become filled with undigested substrates, which explains inclusion cell disease as an alternative name for this disease. In this study, we revealed various cellular phenotypes in ML-II skin fibroblasts. We quantitated phospholipid and cholesterol within cells and showed ~2-fold accumulation in ML-II as compared with normal cells. Lysosomal pH of ML-II cells was higher than that of normal cells (5.29 ± 0.08 versus 4.79 ± 0.10, p < 0.001). The proliferated lysosomes in ML-II cells were accumulated ~3-fold in amount as compared with normal cells. Intracellular logistics including endocytosis and mannose 6-phosphate receptor recycling were impaired in ML-II cells. To confirm whether these ML-II cellular phenotypes derive from deficient lysosomal acid hydrolases within lysosomes, we performed supplementation of lysosomal enzymes using a partially purified total enzyme mixture, which was derived from the conditioned culture medium of normal skin fibroblasts after NH(4)Cl treatment. This supplementation corrected all of the previously described ML-II phenotypes. In addition, the autophagic and mitochondrial impairment that we have previously reported improved, and inclusion bodies disappeared on electron micrography following total lysosomal enzyme supplementation. Our results indicate that various cellular phenotypes in ML-II are caused by the deficiency of many lysosomal enzymes and massive accumulation of undigested substrates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846724      PMCID: PMC3186395          DOI: 10.1074/jbc.M111.267930

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Elevated lysosomal pH in Mucolipidosis type IV cells.

Authors:  G Bach; C S Chen; R E Pagano
Journal:  Clin Chim Acta       Date:  1999-02       Impact factor: 3.786

2.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

3.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; N Gazzah; M C Juge; P G Pentchev; A Revol; P Louisot
Journal:  Biochim Biophys Acta       Date:  1991-06-05

4.  Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase.

Authors:  Stephan Tiede; Stephan Storch; Torben Lübke; Bernard Henrissat; Ruth Bargal; Annick Raas-Rothschild; Thomas Braulke
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

5.  Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

Authors:  R Schiffmann; G J Murray; D Treco; P Daniel; M Sellos-Moura; M Myers; J M Quirk; G C Zirzow; M Borowski; K Loveday; T Anderson; F Gillespie; K L Oliver; N O Jeffries; E Doo; T J Liang; C Kreps; K Gunter; K Frei; K Crutchfield; R F Selden; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport.

Authors:  T Kobayashi; M H Beuchat; M Lindsay; S Frias; R D Palmiter; H Sakuraba; R G Parton; J Gruenberg
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

Review 7.  Enzyme replacement and enhancement therapies for lysosomal diseases.

Authors:  R J Desnick
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

8.  Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.

Authors:  N W Barton; F S Furbish; G J Murray; M Garfield; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial.

Authors:  A Amalfitano; A R Bengur; R P Morse; J M Majure; L E Case; D L Veerling; J Mackey; P Kishnani; W Smith; A McVie-Wylie; J A Sullivan; G E Hoganson; J A Phillips; G B Schaefer; J Charrow; R E Ware; E H Bossen; Y T Chen
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

10.  Effects of ammonia on processing and secretion of precursor and mature lysosomal enzyme from macrophages of normal and pale ear mice: evidence for two distinct pathways.

Authors:  J A Brown; E K Novak; R T Swank
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

View more
  16 in total

1.  Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting.

Authors:  Megan Aarnio-Peterson; Peng Zhao; Seok-Ho Yu; Courtney Christian; Heather Flanagan-Steet; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2017-07-19       Impact factor: 5.157

2.  Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet.

Authors:  Gesine Saher; Fabian Rudolphi; Kristina Corthals; Torben Ruhwedel; Karl-Friedrich Schmidt; Siegrid Löwel; Payam Dibaj; Benoit Barrette; Wiebke Möbius; Klaus-Armin Nave
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

3.  Site-1 protease-activated formation of lysosomal targeting motifs is independent of the lipogenic transcription control.

Authors:  Sarah Klünder; Jörg Heeren; Sandra Markmann; René Santer; Thomas Braulke; Sandra Pohl
Journal:  J Lipid Res       Date:  2015-06-24       Impact factor: 5.922

4.  Autophagosome-lysosome fusion in neurons requires INPP5E, a protein associated with Joubert syndrome.

Authors:  Junya Hasegawa; Ryo Iwamoto; Takanobu Otomo; Akiko Nezu; Maho Hamasaki; Tamotsu Yoshimori
Journal:  EMBO J       Date:  2016-06-23       Impact factor: 11.598

5.  Cargo sorting at the trans-Golgi network at a glance.

Authors:  Charlotte Ford; Anup Parchure; Julia von Blume; Christopher G Burd
Journal:  J Cell Sci       Date:  2021-12-06       Impact factor: 5.285

Review 6.  Understanding amphisomes.

Authors:  Dhasarathan Ganesan; Qian Cai
Journal:  Biochem J       Date:  2021-05-28       Impact factor: 3.857

7.  Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.

Authors:  Minjeong Jung; Jaemeun Lee; Hye-Young Seo; Ji Sun Lim; Eun-Kyoung Kim
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

Review 8.  Lysosomal Storage Diseases-Regulating Neurodegeneration.

Authors:  Rob U Onyenwoke; Jay E Brenman
Journal:  J Exp Neurosci       Date:  2016-04-05

9.  Clathrin-mediated endocytosis is impaired in type A-B Niemann-Pick disease model cells and can be restored by ICAM-1-mediated enzyme replacement.

Authors:  Jeff Rappaport; Carmen Garnacho; Silvia Muro
Journal:  Mol Pharm       Date:  2014-06-26       Impact factor: 4.939

10.  First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro.

Authors:  Alberto Canfrán-Duque; Luis C Barrio; Milagros Lerma; Gema de la Peña; Jorge Serna; Oscar Pastor; Miguel A Lasunción; Rebeca Busto
Journal:  Int J Mol Sci       Date:  2016-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.